Vident Advisory’s Oscar Health OSCR Stock Holding History

Vident Advisory’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.33M	Buy	+46,626	New	+$1M	0.01%	839

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vident Advisory's OSCR Position: Q2 2026 in Review

Vident Advisory opened a new position in Oscar Health (OSCR) in Q2 2026: 46,626 shares worth $1.33M. The stake represents 0.01% of the portfolio and ranks #839 among its holdings.

402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

Vident Advisory held 46,626 shares of Oscar Health worth $1.33M as of Q2 2026.
Oscar Health was a new Vident Advisory position in Q2 2026.
Oscar Health made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #839 holding.
402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.